CANTOR FITZGERALD, L. P. - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 36 filers reported holding PHOENIX BIOTECH ACQUISITION in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CANTOR FITZGERALD, L. P. ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q2 2024$8,865
-74.8%
441,0480.0%0.00%
-75.0%
Q1 2024$35,239
+312.5%
441,048
+21.3%
0.01%
+300.0%
Q4 2023$8,543
-67.2%
363,5480.0%0.00%
+100.0%
Q3 2023$26,030
+17.2%
363,5480.0%0.00%0.0%
Q2 2023$22,213
+52.4%
363,5480.0%0.00%
Q1 2023$14,578
+91012.5%
363,5480.0%0.00%
Q4 2022$16
-99.9%
363,5480.0%0.00%
-100.0%
Q3 2022$29,000
-19.4%
363,5480.0%0.00%0.0%
Q2 2022$36,000
-54.4%
363,5480.0%0.00%
-83.3%
Q1 2022$79,000
-50.0%
363,548
-3.1%
0.01%
-45.5%
Q4 2021$158,000375,0000.01%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q2 2024
NameSharesValueWeighting ↓
Atalaya Capital Management LP 424,867$8,4970.02%
PERISCOPE CAPITAL INC. 427,634$8,5950.00%
Q Global Advisors, LLC 170,785$30.00%
CANTOR FITZGERALD, L. P. 441,048$8,8650.00%
MMCAP International Inc. SPC 375,000$7,5380.00%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 829,598$16,5920.00%
Silver Rock Financial LP 12,224$2460.00%
TENOR CAPITAL MANAGEMENT Co., L.P. 50,000$1,0050.00%
Walleye Trading LLC 88,074$1,7700.00%
Ancora Advisors LLC 2,500$500.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders